Association of HLA-DRB1 Alleles with Ulcerative Colitis in the City of Kerman, South Eastern Iran
-
Mojgan Mohammadi
,
Maryam Rastin
,
Houshang Rafatpanah
,
Haleh Abdoli-Sereshki
,
MohammadJavad Zahedi
,
AminReza Nikpoor
,
Mohammad Reza Baneshi
,
Mohammad Mahdi Hayatbakhsh
Abstract
The association of HLA class II genes with ulcerative colitis (UC) as an autoimmune disease has been investigated for several years. However, factors responsible for genetic predisposition of this disease have so far not been clearly understood. In this study, for the first time, we aimed to investigate the association between HLA-DRB1 types and UC in the population of Kerman, a city southeast Iran. HLA typing was performed among 85 UC patients and 95 healthy controls using PCRamplification, employing sequence specific primers (PCR-SSP). The DRB1 frequencies were determined in the patients and controls. HLA-DRB1*04 was negatively associated with UC. Furthermore, HLA-DRB1*13 was significantly associated with severity of the disease (p=0.01) among UC patients. This is the novel result that describes an association of HLA-DRB1*13 with UC and also shows the protective role of HLA-DRB1*04 against the disease in people of Kerman.
1. Lu XC, Tao Y ,Wu C, Zhao PL, Li K, Zheng JY, et al.Association between Variants of the Autophagy Related Gene–IRGM and Susceptibility to Crohn’s Disease and Ulcerative Colitis: A Meta-Analysis. PloS one 2013;8(11):e80602.
2. Ahmad T, Marshall SE, Jewell D. Genetics of inflammatory bowel disease: the role of the HLA complex. World J Gastroenterol 2006; 12(23):3628-35.
3. Bonen DK, Cho JH. The genetics of inflammatory bowel disease. Gastroenterology 2003; 124(2):521-36.
4. Schwab M, Schaeffeler E, Marx C, Fromm MF, Kaskas B, Metzler J, et al. Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis. Gastroenterology 2003; 124(1):26-33.
5. Hayatbakhsh MM, Zahedi MJ, Shafiepour M, Nikpoor AR, Mohammadi M. IL-23 Receptor Gene rs7517847 and rs1004819 SNPs in Ulcerative Colitis. Iran J Immunol 2012; 9(2):128-35.
6. Rigoli L, Romano C, Caruso RA, Presti MAL, Di Bella C, Procopio V, et al. Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel disease. World J Gastroenterol 2008; 14(28):4454-61.
7. Mohammadi M, Zahedi MJ, Nikpoor AR, Baneshi MR, Hayatbakhsh MM. Interleukin-17 Serum Levels and TLR4 Polymorphisms in Ulcerative Colitis. Iran J Immunol 2013; 10(2):83-92.
8. Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, McLeod RS, Griffiths AM, et al. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 2000; 66(6):1863-70.
9. Dechairo B, Dimon C, van Heel D, Mackay I, Edwards M, Scambler P, et al. Replication and extension studies of inflammatory bowel disease susceptibility regions confirm linkage to chromosome 6p (IBD3). Eur J Hum Genet 2001; 9(8):672-33.
10. Hampe J, Shaw SH, Saiz R, Leysens N, Lantermann A, Mascheretti S, et al .Linkage of inflammatory bowel disease to human chromosome 6p. Am J Hum Genet 1999; 65(6):1647-55.
11. Annese V, Piepoli A, Latiano A, Lombardi G, Napolitano G, Caruso N, et al. HLA-DRB1 alleles may influence disease phenotype in patients with inflammatory bowel disease: a critical reappraisal with review of the literature. Dis Colon Rectum 2005; 48(1):57-64.
12. Fernández AM, López NG, De la Concha E, Figueredo M, Santa Cruz S, Dumitru C, et al. HLA-DR2 gene and Spanish patients with ulcerative colitis. Rev Esp Enferm Dig 1998; 90(4):243-9
13. Uyar FA, Imeryüz N, Saruhan-Direskeneli G, Ceken H,Ozdoğan O, Sahin S, et al. The distribution ofHLA‐DRB alleles in ulcerative colitis patients in Turkey. Rev Esp Enferm Dig 1998; 25(4):293-6.
14. Trachtenberg EA, Yang H, Hayes E, Vinson M, Lin C, Targan SR, et al. HLA class II haplotype associations with inflammatory bowel disease in Jewish (Ashkenazi) and non-Jewish caucasian populations. Hum Immunol 2000; 61(3):326-33.
15. Myung SJ, Yang SK, Jung HY, Chang HS, Park J, Hong WS, et al. HLA-DRB1* 1502 confers susceptibility to ulcerative colitis, but is negatively associated with its intractability: a Korean study. Int J Colorectal Dis 2002;17(4):233-7.
16. Aizawa H, Kinouchi Y, Negoro K, NomuraE, Imai G,Takahashi S, et al. HLA‐B is the best candidate of susceptibility genes in HLA for Japanese ulcerative colitis. Tissue antigens 2009; 73(6):569-74.
17. Yamamoto‐Furusho J, Rodríguez‐Bores L, Granados J.HLA‐DRB1 alleles are associated with the clinical course of disease and steroid dependence in Mexican patients with ulcerative colitis. Colorectal Dis 2010; 12(12):1231-5.
18. Bouzid D, Kammoun A, Amouri A, Mahfoudh N, Haddouk S, Tahri N, et al. Inflammatory bowel disease: susceptibility and disease heterogeneity revealed by human leukocyte antigen genotyping. Genet Test Mol Biomarkers 2012; 16(6):482-7.
19. Froutan H, Nikbin B, Habibabadi M. HLA typing of ulcerative colitis in Iran. Acta Media Iranica 1996; 34(1-2):52-4.
20. Forootan H, Nikbin B, Anani sarab G. Ulcerative colitis and HLA class II phenotyping in Iran. MJIRI 2001;15(1):7-9.
21. Farrokhyar F, Swarbrick E, Irvine EJ. A critical review of epidemiological studies in inflammatory bowel disease. Scand J Gastroenterol 2001; 36(1):2-15.
22. Miller SS, Dykes DD, Polesky HF. Asimple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16(3):1215.
23. Amirzargar A, Mytilineos J, Farjadian S, Doroudchi M, Scherer S, Opelz G, et al. Human leukocyte antigen class II allele frequencies and haplotype association in Iranian normal population. Hum Immunol 2001; 62(11):1234-8.
24. Farjadian S, Naruse T, Kawata H, Ghaderi A, Bahram S, Inoko H. Molecular analysis of HLA allele frequencies and haplotypes in Baloch of Iran compared with related populations of Pakistan. Tissue antigens 2004; 64(5):581-7.
25. Ghaderi A, Shoshtari J, Farjadian S, Yousefi-pour G, Amirzargar A. HLA-DRBI Allele frequency in Myasthenia gravis patients from southern Iran. MJIRI 2000; 14(3):223-5.
26. Kalanie H, Kamgooyan M, Kholghie Y, Harandi AA, Hosseinzadeh Z. HLA allele frequencies in Iranian opticospinal multiple sclerosis patients HLA in Opticospinal MS. JBiSE 2011;4(07):511.
27. Abolfazli R, Samadzadeh S, Sabokbar T, Siroos B, Armaki SA, Aslanbeiki B, et al. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran. J Neurol Sci 2014; 345(1-2):92-6.
28. Wucherpfennig KW, Strominger JL. Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules :a mechanism for MHC-linked susceptibility to human autoimmune diseases. J Exp Med 1995; 181(5):1597-601.
29. Stokkers P, Reitsma P, Tytgat G, Van Deventer SJ. HLA- DR and-DQ phenotypes in inflammatory bowel disease: a meta-analysis. Gut 1999; 45(3):395-401.
30. Ahmad T, Armuzzi A, Neville M, Bunce M, Ling KL, Welsh KI, et al. The contribution of human leucocyte antigen complex genes to disease phenotype in ulcerative colitis. Tissue Antigens 2003; 62(6):527-35.
31. Ahn S, Choi H-B, Kim TG. HLA and disease associations in Koreans. Immune Netw 2011; 11(6):324-35.
32. Howson JM, Roy M, Zeitels L, Stevens H, Todd JA.HLA class II gene associations in African American Type 1 diabetes reveal a protective HLA‐DRB1* 03 haplotype.Diabet Med 2013; 30(6):710-6.
33. Cordovado SK, Zhao Y, Warram JH, Gong H, Anderson KL, Hendrix MM, et al. Nephropathy in Type 1 Diabetes Is Diminished in Carriers of HLA-DRB1* 04 The Genetics of Kidneys in Diabetes (GoKinD) Study. Diabetes 2008; 57(2):518-22.
34. Lundström E, Gustafsson JT, Jönsen A, Leonard D,Zickert A, Elvin K, et al. HLA-DRB1* 04/* 13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus. Ann Rheum Dis 2013;72(6):1018-25.
| Files | ||
| Issue | Vol 14, No 3 (2015) | |
| Section | Original Article(s) | |
| Keywords | ||
| HLA-DRB1 IBD Iran PCR-SSP Ulcerative colitis | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
